<p>根据 MarketBeat Ratings 的报告，目前覆盖 Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）的九位分析师对该股票给予了 “持有” 的共识评级。两位投资分析师给予该股票卖出评级，两位给予持有评级，四位给予买入评级，一位给予强烈买入评级。在过去一年中，给予该股票评级的券商的平均 12 个月目标价为 21.56 美元。</p>
<p>一些股票分析师对该股票发表了看法。瑞银集团在 10 月 7 日（星期一）的一份研究报告中开始覆盖 Oscar Health 的股票。他们对该股票设定了 “中性” 评级和 23.00 美元的目标价。美国银行在 11 月 6 日（星期三）的一份报告中将 Oscar Health 的评级从 “中性” 下调至 “表现不佳”，并将该公司的目标价从 21.00 美元下调至 13.50 美元。最后，杰弗瑞金融集团在 12 月 10 日（星期二）的一份研究报告中开始覆盖 Oscar Health。他们对该公司设定了 “表现不佳” 的评级和 12.00 美元的目标价。</p>
<p><strong>查看我们关于 OSCR 的最新报告</strong></p>
<h2>Oscar Health 股票表现</h2>
<p>Oscar Health 的股票在星期五开盘价为 14.12 美元。该股票的 50 日移动平均价格为 15.10 美元，200 日移动平均价格为 16.89 美元。Oscar Health 的 52 周最低价为 9.70 美元，52 周最高价为 23.79 美元。该公司的市值为 34.9 亿美元，市盈率为-235.29，贝塔值为 1.70。该公司的流动比率为 0.73，速动比率为 0.73，债务与股本比率为 0.26。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近在 11 月 7 日（星期四）发布了季度财报。该公司报告本季度每股收益为（0.22 美元），低于分析师的共识预期（0.20 美元）0.02 美元。Oscar Health 的净利润率为 0.35%，股本回报率为 2.79%。该公司本季度的收入为 24.2 亿美元，而分析师预期为 23.3 亿美元。在去年同期，该公司的每股收益为（0.29 美元）。与去年同期相比，该公司的收入增长了 68.3%。股票研究分析师预计 Oscar Health 在本年度将发布-0.01 美元的每股收益。</p>
<h2>Oscar Health 的内部活动</h2>
<p>在其他新闻中，副董事长 Joshua Kushner 在 11 月 11 日（星期一）以 276,040 股的交易量购买了该公司的股票。每股平均购买价格为 13.58 美元，总交易额为 3,748,623.20 美元。完成购买后，该内部人士现在直接拥有 5,031,262 股公司股票，价值 68,324,537.96 美元。这代表其持股增加了 5.80%。该交易已在向证券交易委员会提交的文件中披露，您可以通过此链接访问。此外，董事 Thrive Partners Vii Growth Gp 在 11 月 12 日（星期二）以 420,819 股的交易量购买了该公司的股票。该股票的平均购买价格为 13.68 美元，总价值为 5,756,803.92 美元。完成交易后，该董事现在拥有 5,452,081 股公司股票，价值约 74,584,468.08 美元。这代表其持股增加了 8.36%。该购买的披露信息可以在这里找到。在过去的 90 天里，内部人士购买了价值 14,432,852 美元的 1,055,478 股公司股票，并出售了价值 1,847,519 美元的 103,610 股股票。公司内部人士拥有公司 25.11% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>一些大型投资者最近调整了他们对 OSCR 的持股。Westfield Capital Management Co. LP 在第三季度收购了 Oscar Health 的新股份，价值约为 27,452,000 美元。摩根大通在第三季度将其在 Oscar Health 的持股增加了 68.5%。摩根大通现在拥有 2,309,150 股公司股票，价值 48,977,000 美元，此前在该期间内又购买了 938,742 股。文艺复兴科技公司在第二季度将其在 Oscar Health 的持股增加了 31.7%。文艺复兴科技公司现在拥有 3,886,100 股公司股票，价值 61,478,000 美元，此前在该期间内又购买了 934,600 股。Point72 资产管理公司在第二季度购买了 Oscar Health 的新股份，价值约为 14,716,000 美元。最后，索罗斯基金管理公司在第三季度收购了 Oscar Health 的新股份，价值约为 12,726,000 美元。目前 75.70% 的股票由机构投资者持有。</p>
<h2>Oscar Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Oscar Health, Inc.在美国运营作为一家健康保险公司。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转变。它还提供再保险产品。</p>
<h2>推荐阅读</h2>
<ul>
<li>我们更看好的五只股票，而不是 Oscar Health</li>
<li>如何选择顶级评级股票</li>
<li>3 只受益于预算和利率压力的防御性股票</li>
<li>哪里可以找到财报电话会议记录</li>
<li>3 只天然气股票将在这个冬季的寒冷中蓬勃发展</li>
<li>投资于建筑股票</li>
<li>看好运动休闲服？这就是 Lululemon 股票闪耀的原因</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中被评为 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

<p>奥斯卡健康公司（Oscar Health, Inc.）（纽约证券交易所代码：OSCR）获得了九位分析师的 “持有” 共识评级。12 个月的平均目标价为 21.56 美元。最近的评级包括瑞银集团的 “中性” 评级，目标价为 23.00 美元， 美国银行的下调至 “表现不佳”，目标价为 13.50 美元，以及杰富瑞的 “表现不佳”，目标价为 12.00 美元。该股票开盘价为 14.12 美元，52 周范围为 9.70 美元至 23.79 美元。奥斯卡健康在上个季度报告的收入为 24.2 亿美元，未能达到每股收益预期，但同比收入增长 68.3%。内部人士最近显著增加了他们的持股</p>

<p>Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have been given a consensus rating of &#34;Hold&#34; by the nine analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $21.56.</p>
<div class="lb-trans"><p>根据 MarketBeat Ratings 的报告，目前覆盖 Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）的九位分析师对该股票给予了 “持有” 的共识评级。两位投资分析师给予该股票卖出评级，两位给予持有评级，四位给予买入评级，一位给予强烈买入评级。在过去一年中，给予该股票评级的券商的平均 12 个月目标价为 21.56 美元。</p>
</div><p>A number of equities analysts have weighed in on the stock. UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a &#34;neutral&#34; rating and a $23.00 price target on the stock. Bank of America cut Oscar Health from a &#34;neutral&#34; rating to an &#34;underperform&#34; rating and reduced their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Jefferies Financial Group initiated coverage on Oscar Health in a research note on Tuesday, December 10th. They set an &#34;underperform&#34; rating and a $12.00 price target for the company.</p>
<div class="lb-trans"><p>一些股票分析师对该股票发表了看法。瑞银集团在 10 月 7 日（星期一）的一份研究报告中开始覆盖 Oscar Health 的股票。他们对该股票设定了 “中性” 评级和 23.00 美元的目标价。美国银行在 11 月 6 日（星期三）的一份报告中将 Oscar Health 的评级从 “中性” 下调至 “表现不佳”，并将该公司的目标价从 21.00 美元下调至 13.50 美元。最后，杰弗瑞金融集团在 12 月 10 日（星期二）的一份研究报告中开始覆盖 Oscar Health。他们对该公司设定了 “表现不佳” 的评级和 12.00 美元的目标价。</p>
</div><p><strong>View Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 OSCR 的最新报告</strong></p>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表现</h2>
</div><p>Oscar Health stock opened at $14.12 on Friday. The stock has a fifty day moving average price of $15.10 and a 200 day moving average price of $16.89. Oscar Health has a 52 week low of $9.70 and a 52 week high of $23.79. The firm has a market capitalization of $3.49 billion, a P/E ratio of -235.29 and a beta of 1.70. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.</p>
<div class="lb-trans"><p>Oscar Health 的股票在星期五开盘价为 14.12 美元。该股票的 50 日移动平均价格为 15.10 美元，200 日移动平均价格为 16.89 美元。Oscar Health 的 52 周最低价为 9.70 美元，52 周最高价为 23.79 美元。该公司的市值为 34.9 亿美元，市盈率为-235.29，贝塔值为 1.70。该公司的流动比率为 0.73，速动比率为 0.73，债务与股本比率为 0.26。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same period in the prior year, the company earned ($0.29) EPS. The company's revenue was up 68.3% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health will post -0.01 earnings per share for the current year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近在 11 月 7 日（星期四）发布了季度财报。该公司报告本季度每股收益为（0.22 美元），低于分析师的共识预期（0.20 美元）0.02 美元。Oscar Health 的净利润率为 0.35%，股本回报率为 2.79%。该公司本季度的收入为 24.2 亿美元，而分析师预期为 23.3 亿美元。在去年同期，该公司的每股收益为（0.29 美元）。与去年同期相比，该公司的收入增长了 68.3%。股票研究分析师预计 Oscar Health 在本年度将发布-0.01 美元的每股收益。</p>
</div><h2>Insider Activity at Oscar Health</h2>
<div class="lb-trans"><h2>Oscar Health 的内部活动</h2>
</div><p>In other news, Vice Chairman Joshua Kushner acquired 276,040 shares of the business's stock in a transaction on Monday, November 11th. The shares were purchased at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now directly owns 5,031,262 shares of the company's stock, valued at $68,324,537.96. This represents a 5.80 % increase in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the firm's stock in a transaction dated Tuesday, November 12th. The stock was purchased at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the transaction, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，副董事长 Joshua Kushner 在 11 月 11 日（星期一）以 276,040 股的交易量购买了该公司的股票。每股平均购买价格为 13.58 美元，总交易额为 3,748,623.20 美元。完成购买后，该内部人士现在直接拥有 5,031,262 股公司股票，价值 68,324,537.96 美元。这代表其持股增加了 5.80%。该交易已在向证券交易委员会提交的文件中披露，您可以通过此链接访问。此外，董事 Thrive Partners Vii Growth Gp 在 11 月 12 日（星期二）以 420,819 股的交易量购买了该公司的股票。该股票的平均购买价格为 13.68 美元，总价值为 5,756,803.92 美元。完成交易后，该董事现在拥有 5,452,081 股公司股票，价值约 74,584,468.08 美元。这代表其持股增加了 8.36%。该购买的披露信息可以在这里找到。在过去的 90 天里，内部人士购买了价值 14,432,852 美元的 1,055,478 股公司股票，并出售了价值 1,847,519 美元的 103,610 股股票。公司内部人士拥有公司 25.11% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of large investors have recently modified their holdings of OSCR. Westfield Capital Management Co. LP acquired a new stake in Oscar Health during the third quarter worth about $27,452,000. JPMorgan Chase &amp; Co. raised its position in shares of Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase &amp; Co. now owns 2,309,150 shares of the company's stock worth $48,977,000 after purchasing an additional 938,742 shares during the period. Renaissance Technologies LLC raised its position in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock worth $61,478,000 after purchasing an additional 934,600 shares during the period. Point72 Asset Management L.P. bought a new stake in shares of Oscar Health in the 2nd quarter worth approximately $14,716,000. Finally, Soros Fund Management LLC acquired a new position in Oscar Health during the 3rd quarter valued at approximately $12,726,000. 75.70% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近调整了他们对 OSCR 的持股。Westfield Capital Management Co. LP 在第三季度收购了 Oscar Health 的新股份，价值约为 27,452,000 美元。摩根大通在第三季度将其在 Oscar Health 的持股增加了 68.5%。摩根大通现在拥有 2,309,150 股公司股票，价值 48,977,000 美元，此前在该期间内又购买了 938,742 股。文艺复兴科技公司在第二季度将其在 Oscar Health 的持股增加了 31.7%。文艺复兴科技公司现在拥有 3,886,100 股公司股票，价值 61,478,000 美元，此前在该期间内又购买了 934,600 股。Point72 资产管理公司在第二季度购买了 Oscar Health 的新股份，价值约为 14,716,000 美元。最后，索罗斯基金管理公司在第三季度收购了 Oscar Health 的新股份，价值约为 12,726,000 美元。目前 75.70% 的股票由机构投资者持有。</p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司简介</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美国运营作为一家健康保险公司。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转变。它还提供再保险产品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐阅读</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>How to Choose Top Rated Stocks</li>
<li>3 Defense Stocks Gaining From Budget and Interest Rate Pressures</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>3 Natural Gas Stocks Set to Thrive in This Winter's Freeze</li>
<li>Investing in Construction Stocks</li>
<li>Bullish on Athleisure? Here’s Why Lululemon Stock Shines</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Oscar Health</li>
<li>如何选择顶级评级股票</li>
<li>3 只受益于预算和利率压力的防御性股票</li>
<li>哪里可以找到财报电话会议记录</li>
<li>3 只天然气股票将在这个冬季的寒冷中蓬勃发展</li>
<li>投资于建筑股票</li>
<li>看好运动休闲服？这就是 Lululemon 股票闪耀的原因</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中被评为 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oscar Health, Inc. (NYSE:OSCR) 获得券商的平均评级为 “持有”